BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17634502)

  • 1. Health care disparity: an overlooked problem in phase I oncology trials.
    O'Brien TE
    J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the institutional submission and approval process for clinical research protocols in oncology.
    Camacho LH; Marubio L; Purdom MA; Leonard D; Hong DS; Moulder S; Pilat SR; Kurzrock R
    J Clin Oncol; 2007 Apr; 25(12):1632-3. PubMed ID: 17443009
    [No Abstract]   [Full Text] [Related]  

  • 3. Discrete event simulation applied to pediatric phase I oncology designs.
    Barrett J; Skolnik J; Jayaraman B; Patel D; Adamson P
    Clin Pharmacol Ther; 2008 Dec; 84(6):729-33. PubMed ID: 18923388
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase III trials in oncology: setting standards of care?
    Seeber S; Braun AH
    Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
    [No Abstract]   [Full Text] [Related]  

  • 5. The phase III candidate: can we improve the science of selection?
    Bajorin D
    J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
    [No Abstract]   [Full Text] [Related]  

  • 6. Participants in phase 1 oncology research trials: are they vulnerable?
    Seidenfeld J; Horstmann E; Emanuel EJ; Grady C
    Arch Intern Med; 2008 Jan; 168(1):16-20. PubMed ID: 18195190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.
    Basso U; Tonti S; Bassi C; Brunello A; Pasetto LM; Scaglione D; Falci C; Beda M; Aversa SM; Stefani M; Castegnaro E; Tamellini F; Monfardini S
    Crit Rev Oncol Hematol; 2008 May; 66(2):163-70. PubMed ID: 18243726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 clinical trials in oncology.
    Muggia FM
    N Engl J Med; 2005 Jun; 352(23):2451-3; author reply 2451-3. PubMed ID: 15948269
    [No Abstract]   [Full Text] [Related]  

  • 9. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment regarding benefit in phase 1 oncology trials.
    Morse M
    Clin Trials; 2008; 5(6):626; discussion 630. PubMed ID: 19029212
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights from the 29th European Society for Medical Oncology Congress: Vienna, Austria, October 29 through November 2, 2004.
    Price N
    Clin Prostate Cancer; 2004 Dec; 3(3):136-40. PubMed ID: 15636678
    [No Abstract]   [Full Text] [Related]  

  • 13. Enrollment of minorities in clinical trials: did we overcome the barriers?
    Fouad MN
    Contemp Clin Trials; 2009 Mar; 30(2):103-4. PubMed ID: 19244624
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of questionnaire to 56 medical institutions about clinical trials of cancer chemotherapy].
    Kurihara M; Matsukawa M; Satoh A; Shimada K; Asaumi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):916-25. PubMed ID: 10396318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The curse of the cure.
    DeVita VT
    Nat Clin Pract Oncol; 2005 Jan; 2(1):1. PubMed ID: 16264829
    [No Abstract]   [Full Text] [Related]  

  • 16. Minority recruitment and participation in health research.
    Corbie-Smith GM
    N C Med J; 2004; 65(6):385-7. PubMed ID: 15714732
    [No Abstract]   [Full Text] [Related]  

  • 17. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

  • 18. Long overdue: phase II studies in older cancer patients: where does the FDA stand?
    Balducci L; Tam-McDevitt J; Hauser R; Simon J
    J Clin Oncol; 2008 Mar; 26(8):1387-88. PubMed ID: 18323564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phase I clinical trials in oncology: a moral dilemma for the investigators].
    Seligmann M
    Presse Med; 2003 Feb; 32(4):147-8. PubMed ID: 12610469
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks and benefits of phase 1 oncology trials, revisited.
    Kurzrock R; Benjamin RS
    N Engl J Med; 2005 Mar; 352(9):930-2. PubMed ID: 15745986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.